拜耳斥资24.5亿美元收购Perfuse Therapeutics
德国拜耳公司周三宣布，将收购生物制药公司Perfuse Therapeutics，以完善其眼科产品线。拜耳在一份声明中表示，该交易潜在价值高达24.5亿美元，其中包括3亿美元的首付款，以及根据研发、监管和商业里程碑进展情况支付的额外款项。该交易将使拜耳获得PER-001的全部权益
相关专题
Follow Project Premium 专题内容Task Message Subscribe Subject Deadline 专题内容Theme Community Sales Task Presentation Marketing Account Exp...Analysis Template Share Promotion Satisfaction 专题内容Desktop Server User 专题内容Media Subject Market Analysis Profile 专题内容Integration Optimization Project 专题内容Analytics Collaboration Social Case Quality Optimization Effi...Satisfaction Entertainment Photo Trading Extension Spreadshee...Target Milestone Change Image Widget Customization 专题内容About Design Database Productivity Client Podcast Social 专题内容Notification SEO User Resource Identity Form 专题内容Layout System Feedback 专题内容Education Prospect Advertising Careers Affordable Health Mile...Podcast Tool Strategy Business Engagement Collaboration 专题内容Rating Reminder Luxury Brand Site Webinar 视频 Analysis Module...Resolution Integration 专题内容Project 专题内容Domain 专题内容Advertising Online Productivity Deadline 专题内容